Results 11 to 20 of about 65,308 (255)

CLN6-related continuum phenotype caused by aberrant splicing. [PDF]

open access: yesEpilepsia Open
AbstractNeuronal ceroid lipofuscinoses (NCLs) are genetically heterogeneous neurodegenerative disorders, characterized by progressive cognitive and motor decline, epilepsy, visual impairment, and shortened life‐expectancy. CLN6‐related NCLs include both late‐infantile and adult myoclonic form.
Invernizzi F   +16 more
europepmc   +5 more sources

Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders [PDF]

open access: yesExperimental and Molecular Medicine
Effective translation of rare disease diagnosis knowledge into therapeutic applications is achievable within a reasonable timeframe; where mutations are amenable to current antisense oligonucleotide technology.
Htoo A. Wai   +7 more
doaj   +2 more sources

Background splicing as a predictor of aberrant splicing in genetic disease [PDF]

open access: yesRNA Biology, 2022
Mutations of splice sites, auxiliary splicing elements and the splicing machinery cause a wide range of genetic disease. Here we report that many of the complex effects of splicing mutations can be predicted from background splicing information, with emphasis on BRCA1, BRCA2 and DMD.
D. Alexieva   +8 more
openaire   +2 more sources

Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index [PDF]

open access: yesAmerican Journal of Human Genetics, 2023
Vicente A Yépez   +2 more
exaly   +2 more sources

Restoration of correct splicing in IVSI-110 mutation of β-globin gene with antisense oligonucleotides: implications and applications in functional assay development [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2017
Objective(s): The use of antisense oligonucleotides (AOs) to restore normal splicing by blocking the recognition of aberrant splice sites by the spliceosome represents an innovative means of potentially controlling certain inherited disorders affected by
Sima Mansoori Derakhshan   +1 more
doaj   +1 more source

Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease. [PDF]

open access: yesPLoS ONE, 2017
While a base substitution in intron 4 of GLA (IVS4+919G>A) that causes aberrant alternative splicing resulting in Fabry disease has been reported, its molecular mechanism remains unclear.
Wen-Hsin Chang   +5 more
doaj   +1 more source

Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes. [PDF]

open access: yesPLoS ONE, 2013
Aberrant pre-mRNA splice variants of hyaluronan synthase 1 (HAS1) have been identified in malignant cells from cancer patients. Bioinformatic analysis suggests that intronic sequence changes can underlie aberrant splicing.
Jitra Kriangkum   +3 more
doaj   +1 more source

Aberrant RNA Splicing in Cancer [PDF]

open access: yesAnnual Review of Cancer Biology, 2019
RNA splicing, the enzymatic process of removing segments of premature RNA to produce mature RNA, is a key mediator of proteome diversity and regulator of gene expression. Increased systematic sequencing of the genome and transcriptome of cancers has identified a variety of means by which RNA splicing is altered in cancer relative to normal cells ...
Luisa, Escobar-Hoyos   +2 more
openaire   +2 more sources

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome

open access: yesFrontiers in Medicine, 2022
X-linked Alport syndrome (XLAS) is caused by pathogenic variants in COL4A5 and is characterized by progressive kidney disease, hearing loss, and ocular abnormalities.
Tomohiko Yamamura   +6 more
doaj   +1 more source

Aberrant splicing and drug resistance in AML [PDF]

open access: yesJournal of Hematology & Oncology, 2016
The advent of next-generation sequencing technologies has unveiled a new window into the heterogeneity of acute myeloid leukemia (AML). In particular, recurrent mutations in spliceosome machinery and genome-wide aberrant splicing events have been recognized as a prominent component of this disease.
Rosalia de Necochea-Campion   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy